LUNG

Pulmonx Corp

• Simply Wall St·06/07 13:10

  Don't Ignore The Insider Selling In Pulmonx

• TipRanks·06/04 21:20

  Pulmonx Shareholders Back Board, Auditor and Pay Program

• PUBT·06/04 20:05

  Pulmonx shareholders elect Class III directors at annual meeting

• TipRanks·06/04 02:08

  Pulmonx Executives Quietly Unload a Wave of Shares in Coordinated Insider Moves

• PUBT·06/01 20:08

  Pulmonx grants 84,300 RSUs to 17 new hires under inducement plan

• Reuters·06/01 20:05

  PULMONX CORPORATION ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

• PUBT·05/05 05:52

  Pulmonx publishes investor presentation on Zephyr valves for severe emphysema treatment

• TipRanks·05/01 00:58

  Pulmonx Earnings Call: Margin Gains Amid Growth Pause

• TipRanks·04/30 16:36

  Lake Street Remains a Buy on Pulmonx (LUNG)

• TipRanks·04/30 15:31

  Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), AbCellera Biologics (ABCL) and Pulmonx (LUNG)

• Dow Jones·04/30 12:18

  Pulmonx Is Maintained at Buy by D. Boral Capital

• Dow Jones·04/30 12:18

  Pulmonx Price Target Maintained With a $14.00/Share by D. Boral Capital

• TipRanks·04/30 11:20

  Analysts Conflicted on These Healthcare Names: Teladoc (TDOC), Madrigal Pharmaceuticals (MDGL) and Pulmonx (LUNG)

• Seeking Alpha·04/30 05:22

  Pulmonx reiterates $90M-$92M 2026 revenue guidance amid cost cuts and expects return to growth in 2H 2026

• Dow Jones·04/29 20:29

  *Pulmonx 1Q Rev $20.6M >LUNG